Allianz Asset Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,715
Closed -$670K 1683
2025
Q1
$670K Sell
3,715
-387
-9% -$69.8K ﹤0.01% 1338
2024
Q4
$643K Buy
4,102
+1,500
+58% +$235K ﹤0.01% 1346
2024
Q3
$474K Sell
2,602
-1,410
-35% -$257K ﹤0.01% 1427
2024
Q2
$737K Sell
4,012
-546
-12% -$100K ﹤0.01% 1320
2024
Q1
$811K Buy
4,558
+158
+4% +$28.1K ﹤0.01% 1303
2023
Q4
$546K Hold
4,400
﹤0.01% 1388
2023
Q3
$510K Sell
4,400
-2,000
-31% -$232K ﹤0.01% 1438
2023
Q2
$751K Sell
6,400
-1,200
-16% -$141K ﹤0.01% 1224
2023
Q1
$608K Sell
7,600
-4,800
-39% -$384K ﹤0.01% 1387
2022
Q4
$982K Sell
12,400
-50
-0.4% -$3.96K ﹤0.01% 1232
2022
Q3
$867K Sell
12,450
-45,239
-78% -$3.15M ﹤0.01% 1224
2022
Q2
$3.79M Buy
57,689
+27,809
+93% +$1.83M ﹤0.01% 1117
2022
Q1
$1.99M Buy
29,880
+8,721
+41% +$580K ﹤0.01% 1370
2021
Q4
$1.48M Buy
+21,159
New +$1.48M ﹤0.01% 1487
2021
Q3
Sell
-7,859
Closed -$534K 2078
2021
Q2
$534K Buy
7,859
+6
+0.1% +$408 ﹤0.01% 1655
2021
Q1
$605K Sell
7,853
-106
-1% -$8.17K ﹤0.01% 1609
2020
Q4
$478K Sell
7,959
-47
-0.6% -$2.82K ﹤0.01% 1627
2020
Q3
$344K Sell
8,006
-699
-8% -$30K ﹤0.01% 1645
2020
Q2
$361K Sell
8,705
-12,947
-60% -$537K ﹤0.01% 1674
2020
Q1
$937K Sell
21,652
-9,583
-31% -$415K ﹤0.01% 1470
2019
Q4
$1.73M Buy
31,235
+5,759
+23% +$319K ﹤0.01% 1508
2019
Q3
$891K Buy
25,476
+95
+0.4% +$3.32K ﹤0.01% 1721
2019
Q2
$1.02M Sell
25,381
-9,874
-28% -$398K ﹤0.01% 1745
2019
Q1
$1.16M Buy
+35,255
New +$1.16M ﹤0.01% 1713